Poor prognosis for mucin-producing Wilms' tumor

Cancer
|January 15, 1984
PubMed

Insights

Mucin detected in the sera of pediatric Wilms tumor patients indicates a poor prognosis. This finding, observed in familial cases, suggests mucin may drive rapid tumor growth and metastasis.

Area of Science:

  • Pediatric Oncology
  • Cancer Biomarkers
  • Tumorigenesis

Background:

  • Wilms tumor is a common pediatric kidney cancer.
  • Familial clustering of Wilms tumor suggests a genetic component.
  • Prognostic markers are crucial for guiding treatment strategies.

Observation:

  • Two cousins diagnosed with Wilms tumor presented with mucin in their sera.
  • Literature review identified five similar cases of Wilms tumor with serum mucin.
  • All reported patients had metastatic disease at diagnosis.

Findings:

  • Patients with serum mucin exhibited rapidly fatal courses.
  • Four out of five patients died within one year of diagnosis.
  • Serum mucin presence correlates with metastatic Wilms tumor and poor therapeutic response.

Implications:

  • Serum mucin may serve as a significant negative prognostic indicator in Wilms tumor.
  • Mucin production could actively promote tumor progression and metastasis.
  • Further research into the role of mucin in Wilms tumor genetics and behavior is warranted.